IGC Pharma, Inc. — Director's Dealing 2012

Jan 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2011-04-18

Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-03	Warrants	$5	A	200000	Acquired	2013-03-08	Common Stock (200000)	Direct

Footnotes

F1: The derivative securities include 1,326,168 warrants and options.

F2: Includes 28,571 warrants exercisable at $5.00, held by Parveen Mukunda.